Human LRG1 PharmaGenie ELISA Kit (SBRS0843)

Leucine-Rich Alpha-2-Glycoprotein 1 (LRG1) is a secreted glycoprotein that has emerged as a biomarker of interest in oncology, cardiovascular disease, and inflammatory research. Published studies have linked circulating LRG1 levels to colorectal and pancreatic tumor progression, heart failure severity, and sepsis outcomes, making reliable quantification valuable across these translational workflows. This Assay Genie immunoassay enables quantitative measurement of human LRG1 across multiple sample matrices, supporting studies of TGF-β–driven angiogenesis, tumor microenvironment signaling, and acute-phase inflammatory responses. The kit is supplied in a 96-assay configuration and employs a colorimetric readout compatible with standard microplate absorbance instruments. Reagents are provided ready to use, allowing researchers to process conditioned media from cell-based experiments alongside clinical samples in the same run. Each package includes the antibody-coated plate and detection components necessary to complete the full plate. Reagents should be refrigerated upon arrival, and the assay is intended for research use only.